Publications by authors named "Elena Fea"

Claim this Profile
P
Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.
Gianmauro Numico, Elena Fea, Rachele Ferrua, Michela Milanesio, Giulia Bernardi

Tumori· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency Care for Patients with Cancer on Immune Checkpoint Inhibitors: A Retrospective Analysis of Immune-Related Adverse Events.
Alice Ferrua, Jacopo Davide Giamello, Chiara Fulcheri, Michela Milanesio, Giulia Bernardi, Elena Fea

J Emerg Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chemotherapy at the end-of-life: the reasons why it is not a good parameter for evaluating clinical choices in oncology].
Gianmauro Numico, Elena Fea

Recenti Prog Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
Monica Niger, Federico Nichetti, Lorenzo Fornaro, Chiara Pircher, Federica Morano, Elena Fea

BMC Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis.
Chiara Pisano, Fabio Turco, Elena Arnaudo, Elena Fea, Paola Vanella

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
Monica Niger, Federico Nichetti, Lorenzo Fornaro, Chiara Pircher, Federica Morano, Elena Fea

BMC Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with cancer and hospital admissions: disease trajectory and strategic choices.
Gianmauro Numico, Rachele Ferrua, Elena Fea, Jacopo Giamello, Ida Colantonio

BMJ Support Palliat Care· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series.
Sebastiano Buti, Melissa Bersanelli, Francesco Massari, Ugo De Giorgi, Orazio Caffo, Elena Fea

World J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network.
Susanna Bianchi, Alessandra Mosca, Alberto Dalla Volta, Veronica Prati, Cinzia Ortega, Elena Fea

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review.
Nerina Denaro, Ornella Garrone, Marcella Occelli, Elena Fea, Cristina Granetto

Eur J Case Rep Intern Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy.
Marco Carlo Merlano, Andrea Abbona, Matteo Paccagnella, Antonella Falletta, Cristina Granetto, Elena Fea

Vaccines (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest.
Roberto Moretto, Daniele Rossini, Gemma Zucchelli, Sara Lonardi, Francesca Bergamo, Elena Fea

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy.
Ornella Garrone, Nerina Denaro, Fiorella Ruatta, Paola Vanella, Cristina Granetto, Elena Fea

Tumori· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib.
Vincenzo Ricci, Cristina Granetto, Antonella Falletta, Matteo Paccagnella, Andrea Abbona, Elena Fea

World J Gastrointest Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide.
Marco C Merlano, Anna M Merlotti, Lisa Licitra, Nerina Denaro, Elena Fea

Clin Transl Radiat Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of colon cancer: from bench to bedside.
Marco C Merlano, Cristina Granetto, Elena Fea, Vincenzo Ricci, Ornella Garrone

ESMO Open· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion.
Gianmauro Numico, Antonella Cristofano, Marcella Occelli, Marco Sicuro, Alessandro Mozzicafreddo, Elena Fea

Medicine (Baltimore)· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.
Cora N Sternberg, Fabio Calabrò, Sergio Bracarda, Giacomo Cartenì, Giovanni Lo Re, Elena Fea

Oncology· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score.
Gianmauro Numico, Marcella Occelli, Elvio G Russi, Nicola Silvestris, Raffaella Pasero, Elena Fea

Support Care Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
Gianmauro Numico, Elvio G Russi, Raffele Vitiello, Raffaele Sorrentino, Ida Colantonio, Elena Fea

Int J Radiat Oncol Biol Phys· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients.
Gianfilippo Bertelli, Abdelhamid Heouaine, Giuseppe Arena, Ambrogio Botto, Ornella Garrone, Elena Fea

Cancer Chemother Pharmacol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy.
Gianmauro Numico, Ida Colantonio, Milena Gasco, Gianfilippo Bertelli, Ornella Garrone, Elena Fea

Anticancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine.
Gianmauro Numico, Ornella Garrone, Vincenzo Dongiovanni, Nicola Silvestris, Ida Colantonio, Elena Fea

Cancer· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study.
Michela Donadio, Mara Ardine, Alfredo Berruti, Giuliana Ritorto, Elena Fea

Cancer Chemother Pharmacol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis